$IBO CO-founder to share his results at a global event
The company recently announced that DR Alberto Sola, CO-Founder of Universal Ibogaine, will present his recent findings in the title Ibogaine Hydrochloride and Acute Opioid Detox.
−0.0046USD
−1.81 MUSD
780.63 KUSD
157.00 M
About Universal Ibogaine Inc.
Sector
CEO
Nicholas Peter Karos
Headquarters
Vancouver
Website
Founded
2018
ISIN
CA91360F1099
FIGI
BBG015MWH6V6
Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The company was founded by Shayne Nyquvest and Alberto Solá Agulló in 2018 and is headquartered in Vancouver, Canada.
Universal Ibogaine Inc.. Market InsightThe trading just got a green signal on the TSX-V, and $IBO zoomed past the fellow penny stocks in a flicker; what a scene it was; I am amazed and satisfied to buy some shares of it
$IBO is playing a fundamental role in the TSXV market Let’s go fellow shareholders of $IBO it is the day to be proud of yourself for trusting in $IBO, I am so enlivened to see this stock reaching the heights it was always meant to reach
Nick Karos jubilant by the listing of UI on Frankfurt stock exch
UI CEO made a statement "Our capital markets and investor relations strategy includes the FSE listing. We recently began trading on the OTCQB Exchange in the United States, and curiosity in the UI story is growing in Europe, particularly Germany. With a mushrooming market and interest in psychedeli
$IBO the apex stock in the market, waiting for your investment
$IBO is moving ahead with courage and compassion on the TSX-V, the stock is expanding in leaps and bounds in the market, shares are effectively trading at $0.0400 with zero loss percentage
$DIA stock stance and ticker review
$DIA has marked a rather brilliant opening on the TSX-V and is moving ahead with an unmatched pace and stock trading at suitable buying price of $0.1800 to generate heavy profit
$IBO on an unbelievable stock rally today on the TSX-V
$IBO don’t ever shy out from attaining peaks in the market and delivering unimaginable profit to the shareholders, the shares are trading yesterday with a massive spike of 10% at $0.0500 with sizeable ascent
Universal Ibogaine’s stock approved by borse Frankfurt
UI's common shares have been listed for trading on the Frankfurt Stock Exchange, or Bourse Frankfurt, under the ticker symbol "JC4". In Canada, UI will continue to trade on the TSX Venture Exchange under the ticker IBO and on the OTCQB under the ticker symbol IBOGF.
$IBO destined to be on top of the TSX-V index
$IBO is one of the handpicked penny stocks in the market today and is racing ahead with full speed, the stock’s financial figures are pretty neat and is expected achieve great heights in the days to come, shares are trading yesterday at $0.0500 with a distinctive spike
Perks handed to UI upon listing on the Frankfurt stock exchangeThe Frankfurt Stock Exchange (FSE) is Germany's largest stock exchange and the leading European destination for Canadian venture capital firms seeking exposure and liquidity in the European market. The FSE enables advanced electronic trading, settlement, and information technologies, allowing it to
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IBOGF is 0.0149 USD — it has increased by 2.05% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Universal Ibogaine Inc. stocks are traded under the ticker IBOGF.
IBOGF stock is 2.01% volatile and has beta coefficient of −2.49. Check out the list of the most volatile stocks — is Universal Ibogaine Inc. there?
Yes, you can track Universal Ibogaine Inc. financials in yearly and quarterly reports right on TradingView.
IBOGF stock has risen by 2.76% compared to the previous week, the month change is a 19.02% fall, over the last year Universal Ibogaine Inc. has showed a 13.74% increase.
IBOGF net income for the last quarter is −165.29 K USD, while the quarter before that showed −149.76 K USD of net income which accounts for −10.37% change. Track more Universal Ibogaine Inc. financial stats to get the full picture.
Today Universal Ibogaine Inc. has the market capitalization of 2.29 M, it has decreased by 13.12% over the last week.
No, IBOGF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IBOGF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Universal Ibogaine Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Universal Ibogaine Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Universal Ibogaine Inc. stock shows the neutral signal. See more of Universal Ibogaine Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Universal Ibogaine Inc. EBITDA is −351.93 K USD, and current EBITDA margin is −170.36%. See more stats in Universal Ibogaine Inc. financial statements.